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Survival data on female invasive breast cancer with 9-year follow-up from five French cancer registries were analysed by logistic
regression for prognostic factors of cancer stage. The Kaplan–Meier method and log-rank test were used to estimate and compare
the overall survival probability at 5 and 7 years, and at the endpoint. The Cox regression model was used for multivariate analysis.
County of residence, age group, occupational status, mammographic surveillance, gynaecological prevention consultations and the
diagnosis mammography, whether within a screening framework or not, were independent prognostic factors of survival. Moreover,
for the same age group, and only for cancers T2 and/or Nþ (whether 1, 2 or 3) and M0, the prognosis was significantly better when
the diagnosis mammography was done within the framework of screening. Socio-economic and surveillance characteristics are
independent prognostic factors of both breast cancer stage at diagnosis and of survival. Screening mammography is an independent
prognostic factor of survival.
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Breast cancer is the commonest type of cancer among women
worldwide, accounting for approximately 20% of all malignancy
and higher in developed western countries (Boyle and Ferlay, 2004;
Parkin et al, 2005); its incidence has been rising in the United
States, Canada, Europe, Singapore and Japan. Many prognostic
factors are well described, but socio-economic factors and
screening mammography have produced contradictory results
(Klemi et al, 2003; Gill et al, 2004; Joensuu et al, 2004). In France,
population-based cancer survival data collected by cancer
registries are useful in assessing the effectiveness of strategies to
control cancer incidence (Chia et al, 2001), but only the Co ˆte d’Or
breast and gynaecologic cancer registry focuses on breast and
gynaecologic cancer. It has been collecting comprehensive
population-based data since 1982.
In this study, we have investigated socio-economic and
surveillance characteristics as prognostic factors for breast cancer
stage at diagnosis and overall survival. We also examined
screening mammography as a prognostic factor for overall survival
of patients with the same stage of breast cancer at diagnosis, and of
patients in the same age group.
MATERIALS AND METHODS
Patients
A sample of 1150 women diagnosed with invasive breast cancer in
1995–1997 was followed up in 2006 to examine the relation of
socio-economic and surveillance characteristics to survival. This
sample was built from five population-based cancer registries in
France and included the following: cases of all breast cancer
diagnosed in incidents in the counties of Doubs (n¼248) and Tarn
(n¼212) in 1997, Co ˆte d’Or (n¼228) over 10 months of 1997 and
as was a random sample of cases in the counties of Bas-Rhin
(n¼193) in 1995 and Ise `re (n¼269) in 1997; in situ breast cancer
and cases in men were not included.
For all patients, we gathered follow-up data such as life status,
last news or date of death, the date of any relapse or metastasis of
breast cancer and type and place of treatment. Follow-up
questionnaires were completed by the registries and centralized
in the Co ˆte d’Or registry, where the data were entered into a
database. The registries ascertained the life status of patients from
various sources (e.g., RNIPP (Re ´pertoire National d’Identification
des Personnes Physiques), town hall of place of birth, death
certificates, medical records, general practitioner or CNAM (Caisse
Nationale d’Assurance Maladie)). Clinical details and treatments
were obtained from clinical records, but when these were
incomplete, the missing data were obtained from the general
practitioner or the specialist using a questionnaire.
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occupational status and, when data were missing, from the level
of education. The occupational status was split into two classes:
low or middle (farmers, artisans, manual workers, unemployed)
and high (executives, middle professional group, clerical employ-
ees). The education level was also split into two classes: low (no
diploma, certificate of primary education, low-level vocational
certificate, low-level professional diploma) and high (high-school
diploma, higher education). The socio-economic status was low or
high when the occupational status was low or high, respectively,
and if the latter was unknown, the socio-economic status was low
or high when the education level was low or high, respectively.
The stage of the primary breast cancer was determined using the
TNM staging system for breast cancer and classified into one of
four categories as follows: stage 1, T1a and T1b N0 M0; stage 2, T1c
N0 M0; stage 3, T2 and/or Nþ (whether 1, 2 or 3) M0 and stage 4,
T3 and 4 and/or M1, whatever the N (0–3).
The five circumstances of diagnostic mammography reduced to
two categories: screening or no screening. The first includes
mammography screening programmes and symptom-free screening
mammography, and the second includes mammographies
performed on clinical symptoms observed by the doctor or the
woman herself, or for women with a high-risk for breast cancer.
Statistical analysis
The statistical analysis was carried out at the Co ˆte d’Or breast
cancer registry. Continuous and qualitative variables were
respectively described by mean, standard deviation, median and
percentage. The percentage of missing values was also provided.
Univariate and multivariate analyses of prognostic factors for stage
1 (T1a or T1b N0 M0) cancer vs all other stages together were
carried out using logistic regression, and the significance level
a¼0.05 was used to select variables for the multivariate model.
The following variables were included: place of residence
(Bas-Rhin, Co ˆte d’Or, Doubs, Ise `re, Tarn), age at diagnosis (o50
years old, 50–70 years old, 470 years old), way of life according to
marital status (alone or not), number of children (0 or 1, 2 or
more); occupational status was divided into two categories, as
described above, socio-economic status (low or high, according to
occupational status and education), number of mammographies
during the 6 years before diagnosis (none or at least one),
gynaecological prevention consultations during the 3 years before
diagnosis (none or at least one). All variables were included in the
multivariate model to calculate the odds ratio (OR) and its 95%
confidence interval (CI). The correlation between these variables
was tested beforehand to explore associations and multi-collinearity.
The follow-up period continued from the date of diagnosis until
death or until June 30, 2006 (data cut-off) if patients were still
living. Overall survival, measured from diagnosis until death (all
causes) or last follow-up, was estimated using the Kaplan–Meier
method, and survival curves were compared using log-rank tests.
For multivariate analysis, the Cox regression model was applied
and the variables analysed were the same as those in the study of
prognostic factors by stage at diagnosis, cancer detected by
screening mammography or not. Hazard ratios (HRs) and their
95% CIs were calculated. Multivariate survival analysis was first
based on significant factors for stage at diagnosis, and then using
stage in the same model. Univariate analyses of survival according
to the circumstances of the diagnosis mammography, including
age and clinical stage subgroups (post hoc analysis), were
performed. For clinical stage subgroups, our original intention
was to analyse the impact of screening on mortality for each stage
separately, but women with stage 1 (T1a or T1b N0 M0) at
diagnosis had much higher survival: among 158 patients, only
three died within 5 years of diagnosis, and so this was combined
with stage 2 (T1c N0 M0) subgroup in the analysis. The same
analysis was performed after separating stage 3 (T2 N0/þ M0)
into three classes: T1 Nþ M0, T2 N0 M0 and T2 Nþ M0. All
calculations were carried out using SAS v 9.1 software and the
significance level a¼0.05 was used.
RESULTS
The patients’ socio-economic and surveillance characteristics are
shown in Table 1. The mean age of patients at diagnosis was 59.9
years (95% CI¼[33.2–86.7]), and was not significantly different
according to the county of residence; 280 (24.3%) were under 50
years old, 569 (49.5%) were 50–70 years old and 292 (25.4%) were
over 70 years old. Three hundred and fifty-four women were living
alone (30.8%), while 705 (61.3%) were not alone. Four hundred
and twenty (36.5%) had either no children or one child, and 730
(63.5%) had two children or more. The two categories of
occupational status were almost equal: 470 (40.9%) were farmers,
artisans, manual workers or unemployed, and 489 (42.5%) were
executives, middle professional group or clerical employees. Socio-
economic status was low for 761 (66.2%) and high for 217 (18.9%)
patients.
With regard to prevention practices, 355 (30.9%) women had no
mammography in the 6 years before diagnosis, and 598 (52.0%)
had had at least one; 194 (16.8%) patients had no gynaecological
consultation in the 3 years before diagnosis, while 547 (47.6%) had
had at least one for contraception, cervical smear or hormone
therapy.
As shown in Table 1, univariate statistical analyses highlighted
the fact that the socio-economic and surveillance characteristics of
the 1150 women with primary breast cancer were significantly
associated with the stage of cancer at diagnosis (stage 1 vs 2, 3 and
4 together), county of residence (Po0.001), age at diagnosis
(Po0.001), way of life according to marital status (Po0.05),
number of children (Po0.001), occupational status (Po0.001),
socio-economic status (Po0.05), number of mammographies
during the 6 years before diagnosis (Po0.001) and gynaecological
prevention consultations during the 3 years before diagnosis
(Po0.001). In multivariate logistic regression analysis, the factors
associated with the probability of having breast cancer diagnosed
stage 1 rather than stage 2, 3 or 4 were county of residence (Co ˆte
d’Or OR¼2.0, 95% CI¼[1.4–3.0]; Ise `re OR¼2.6, 95% CI¼[1.8–
3.8]; Tarn OR¼1.9, 95% CI¼[1.3–2.9]; Po0.001), having two
children or more (OR¼1.9, 95% CI¼[1.4–2.6]; Po0.001),
occupational status ‘executives, middle professional group, clerical
employees’ (OR¼1.4, 95% CI¼[1.02–1.8]; Po0.05), at least one
mammography in the 6 years before diagnosis (OR¼1.8 95%
CI¼[1.3–2.4]; Po0.001), and at least one gynaecological preven-
tion consultation in the 3 years before diagnosis (OR¼1.6, 95%
CI¼[1.2–2.2]; Po0.001).
Among the 1150 women with breast cancer in the study sample,
1135 (98.7%) were followed until June 2006: 815 (70.9%) women
were still alive, 320 (27.8%) had died and 15 (1.3%) were lost to
follow-up. Among the 1011 women without metastasis at the
diagnosis, 515 (50.9%) were still alive without recurrence or
metastasis, 99 (9.8%) were alive but with recurrence of their
cancer, 158 (15.6%) were alive, but had developed metastases more
than six months after diagnosis, while 239 (23.6%) had died.
Among the 1135 patients followed-up, for 250 (22.0%) the cancer
was detected, thanks to a symptom-free screening mammography,
whereas for 755 (66.5%), the diagnosis mammography was
performed because of clinical symptoms observed by the doctor
or the woman herself, or if she was at a high risk for breast cancer.
These data were unknown for 130 (11.5%) patients.
Table 2 shows 5- and 7-year survival rates with the log-rank test,
and the results of the Cox multivariate analysis for overall survival.
Five-year overall survival was 82.3% and 7-year overall survival
was 75.0%.
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county of residence (P¼0.002), age at diagnosis (Po0.001), way of
life (alone or not) (P¼0.003), number of children (P¼0.004),
occupational status (Po0.001), socio-economic status (P¼0.002),
none or at least one mammography during the 6 years before
diagnosis (Po0.001), none or at least one gynaecological
prevention consultation during the 3 years before diagnosis
(Po0.001) and cancer detected by screening mammography or
not (Po0.001) were significantly associated with overall survival.
In multivariate analysis, the county of Ise `re (HR¼0.7, 95%
CI¼[0.5–0.95]; P¼0.024); age over 70 years at diagnosis
(HR¼2.0, 95% CI¼[1.5–2.7]; Po0.001); occupational status
including farmers, artisans, manual workers and unemployed
(HR¼1.4, 95% CI¼[1.0–1.9]; P¼0.050); no mammography in
the 6 years before diagnosis (HR¼1.8, 95% CI¼[1.4–2.3];
Po0.001); no gynaecological prevention consultation in the 3
years before diagnosis (HR¼1.8, 95% CI¼[1.3–2.6]; Po0.001)
and cancer detected on clinical symptoms and not by screening
mammography (HR¼2.2, 95% CI¼[1.5–3.2]; Po0.001) were
significantly associated with overall survival.
After adjustment for stage (Table 3), the factors that were
significant were age above 70 years at diagnosis (HR¼2.0, 95%
CI¼[1.5–2.6]; Po0.001), no mammography during the 6 years
before diagnosis (HR¼1.5, 95% CI¼[1.1–2.0]; P¼0.004), no
gynaecological prevention consultation during the 3 years before
diagnosis (HR¼1.5, 95% CI¼[1.1–2.2]; P¼0.017) and cancer
detected on clinical symptoms and not by screening mammo-
graphy (HR¼1.6, 95% CI¼[1.05–2.3]; P¼0.030).
In the same analysis, stage was significantly associated with
overall survival, in comparison with stage T1 N0 M0: T2 and/or
Nþ (1, 2 or 3) M0 (HR¼2.6, 95% CI¼[1.9–3.6]; Po0.001) and T3
or T4 and/or M1 whatever the N (HR¼7.1, 95% CI¼[4.9–10.3];
Po0.001).
Screening mammography as a prognostic factor of survival
that is independent of age and cancer stage at diagnosis
Because screening mammography, as well as age and stage, is a
prognostic factor (Table 2), we analysed it as a prognostic factor
for overall survival within similar stages and age groups.
Table 1 Patients’ socio-economic and surveillance characteristics, univariate and multivariate logistic regression analysis of prognostic factors for stage at
diagnosis (stage 1 vs stages 2, 3 and 4 together)
Univariate analysis (logistic regression)
a Multivariate analysis (logistic regression)
a
n¼1150 (%)
Odds ratio
[95% CI] P-value
Odds ratio
[95% CI] P-value
County of residence 1 Doubs and Bas-Rhin together
Doubs 248 (21.6) 1
Bas-Rhin 193 (16.8) 1.2 [0.7–2.0] o0.001
Co ˆte d’Or 228 (19.8) 2.0 [1.3–3.1] 2.0 [1.4–3.0]
Ise `re 269 (23.4) 2.5 [1.6–3.7] 2.6 [1.8–3.8] o0.001
Tarn 212 (18.4) 1.6 [1.03–2.5] 1.9 [1.3–2.9]
Age at diagnosis
o50 years old 280 (24.3) 1.7 [1.2–2.6]
50–70 years old 569 (49.5) 2.0 [1.5–2.0] o0.001 NS
470 years old 292 (25.4) 1
Unknown 9 (0.8)
Marital status
Alone 354 (30.8) 1 o0.05 NS
Not alone 705 (61.3) 1.4 [1.04–1.9]
Unknown 91 (7.9)
Number of children
0 or 1 420 (36.5) 1 o0.001 1
2 or more 730 (63.5) 1.6 [1.2–2.2] 1.9 [1.4–2.6] o0.001
Occupational status
Farmers, artisans, manual workers, unemployed 470 (40.9) 1 o0.001 1
Executives, middle professional group, employees 489 (42.5) 1.7 [1.6–2.4] 1.4 [1.02–1.8] o0.05
Unknown 191 (16.6)
Socio-economic status
Low 761 (66.2) 1 o0.05 NS
High 217 (18.9) 1.4 [1.02–2.0]
Unknown 172 (14.9)
Mammographies during the 6 years before diagnosis
None 355 (30.9) 1 1 o0.001
One or more 598 (52.0) 2.4 [1.9–3.0] o0.001 1.8 [1.3–2.4]
Unknown 197 (17.1)
Gynaecological prevention consultation during the 3 years before diagnosis
None 194 (16.8) 1 o0.001 1
One or more 547 (47.6) 2.4 [1.8–3.2] 1.6 [1.2–2.2] o0.001
Unknown 409 (35.6)
Abbreviations: CI¼confidence interval; NS¼not significant.
aUnknown data were not used for the statistical analyses.
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the type of diagnosis mammography (screening or not). The
results for 5-year overall survival and univariate analysis (log-rank
test) by age group and by stage at diagnosis, according to the
circumstances of the diagnosis mammography, are shown in
Table 4.
Among the 253 women under 50 years, 18.2% had their
diagnosis mammography within a screening framework and
81.8% on clinical symptoms or because of a high risk of breast
cancer; 5-year survival for these two groups was 95.7 and 84.1%,
respectively. Among the 514 women aged 50–70 years, the
corresponding proportions were 33.5 and 66.5%, respectively, for
those with 5-year survival of 93.6 and 87.1%, respectively, while
among the 234 women aged over 70 years, these proportions were
13.2 and 86.8% with 5-year survival 93.7 and 66.5%, respectively.
For each age group, patients for whom diagnosis was made in a
screening mammography had significantly better overall survival
than those who underwent mammography after onset of clinical
symptoms, or because they had a high risk of breast cancer
(P¼0.005, P¼0.011 and Po0.001, respectively, for the three age
ranges).
Among the 343 women with stage 1 or 2 cancers (T1 N0 M0),
126 (36.7%) had their diagnosis mammography within a screening
framework and 217 (63.3%) on clinical symptoms or because of a
high risk of breast cancer; 5-year survival for the two groups was
94.4 and 93.1%, respectively; not significantly different. Among
the 391 women with stage 3 cancer (T2 and/or Nþ M0), the
corresponding proportions were 13.3 and 86.7%, respectively, and
5-year survival for the two groups was 98.1 and 77.9%,
respectively, a significant difference (P¼0.002). Among the 91
women with stage 4 cancer (T3 or T4, N0 or þ, and/or M1), these
proportions were 5.7 and 94.3%, respectively, and 5-year survival
for the two groups was 80.0 and 50.6%, respectively.
Survival analysis for the three subclasses of stage 3, T1 Nþ M0,
T2 N0 M0 and T2 Nþ M0, provided significant results. Among the
133 women with stage T1 Nþ M0, 26 (19.5%) had their diagnosis
mammography within screening and 107 (80.5%) on clinical
symptoms or because of a high risk of breast cancer, 5-year
survival for the two groups being 100 and 78.5%, respectively
(P¼0.009); among the 128 women with stage T2 N0 M0, 17
(13.3%) had their diagnosis mammography within the framework
of screening and 111 (86.7%) on clinical symptoms or because of a
high risk of breast cancer, 5-year survival being 94.1 and 82.9%,
respectively (P¼0.046); among the 126 women with stage T2 Nþ
M0, eight (6.3%) had their diagnosis mammography within
screening and 118 (93.7%) on clinical symptoms or because of a
Table 2 Univariate and multivariate analyses of overall survival according to socio-economic and surveillance characteristics (n¼1138)
Overall survival (%) Cox multivariate analysis
5-year
survival (%)
7-year
survival (%)
Univariate analysis
log-rank P-value
Hazard ratio
[95% CI] P-value
County of residence
1 Doubs and Bas-Rhin
together
Doubs 82.4 74.4
Bas-Rhin 79.2 75.5
Co ˆte d’Or 82.2 78.2 0.002 0.9 [0.7–1.3] 0.660
Ise `re 88.9 79.6 0.7 [0.5–0.95] 0.024
Tarn 76.7 66.2 1.0 [0.7–1.4] 0.963
Age at diagnosis
o50 years old 86.2 82.3 1.1 [0.8–1.6] 0.441
50–70 years old 87.9 83.1 o0.001 1
470 years old 67.6 52.4 2.0 [1.5–2.7] o0.001
Marital status
Alone 78.5 69.9 0.003 0.9 [0.7–1.2] 0.557
Not alone 84.2 78.1 1
Number of children
0 or 1 78.3 69.6 0.004 1.2 [0.9–1.5] 0.241
2 or more 84.6 78.2 1
Occupational status
Farmers, artisans, manual workers, unemployed 77.4 69.4 o0.001 1.4 [1.0–1.9] 0.050
Executives, middle professional group, clerical employees 88.2 83.0 1
Socio-economic status
Low 81.9 74.0 0.002 1.0 [0.7–1.5] 0.991
High 89.7 84.5 1
Mammographies during the 6 years before diagnosis
None 72.0 62.9 o0.001 1.8 [1.4–2.3] o0.001
One or more 90.0 85.3 1
Gynaecological consultation
None 73.7 60.5 o0.001 1.8 [1.3–2.6] o0.001
One or more 89.5 85.4 1
Cancer detected by screening mammography
No 80.7 72.6 o0.001 2.2 [1.5–3.2] o0.001
Yes 94.0 91.2 1
Abbreviation: CI¼confidence interval.
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respectively (P¼0.833).
The number of patients who died, in the three subclasses of
stage 3, was too low to make a survival analysis these results must
be then considered as exploratory results.
DISCUSSION
Many studies on breast cancer survival are hospital-based and/or
use basic data on patient and tumour characteristics. As a
complement to studies comparing screening mammography
within a clinical trial (Nystro ¨m et al, 2002) or before and after a
mammography screening programme (Tabar et al, 2003), our
cancer registry data were collected from a well-defined French
population and could thus be considered representative.
Our results support the major role of socio-economic data,
surveillance characteristics and the circumstances of the diagnostic
mammography on overall breast cancer survival, and confirm that
they should be used to improve public health guidance for breast
cancer.
Overall 5- and 7-year crude survival rates were 82.3 and 75.0%,
respectively, for the whole sample. These results are in agreement
with the 5-year relative survival rate of 81.3% published in the
EUROCARE-3 study from French population-based registries
diagnosed in 1990–1994 (Sant et al, 2003a). As highlighted in
our study, survival varied significantly by county (Sant et al,
2003b). This is probably due to differences in the distribution of
stage at diagnosis (Sant et al, 2003b) or to differences in the nature
of the county (more urban or more rural) (Mitchell et al, 2006). We
suggest that surveillance practices (a gynaecology consultation or a
mammography during the years before diagnosis) as well as the
Table 3 Univariate and multivariate analyses of overall survival according to socio-economic and surveillance characteristics plus breast cancer stage at
diagnosis (n¼1138)
Overall survival (%) Cox multivariate analysis
5-year
survival (%)
7-year
survival (%)
Univariate analysis
log-rank P-value
Hazard
ratio [95% CI] P-value
County of residence 1 Doubs and
Bas-Rhin together Doubs 82.4 74.4
Bas-Rhin 79.2 75.5
Co ˆte d’Or 82.2 78.2 0.002 0.9 [0.6–1.2] 0.401
Ise `re 88.9 79.6 0.7 [0.5–1.0] 0.068
Tarn 76.7 66.2 1.1 [0.8–1.4] 0.738
Age at diagnosis
o50 years old 86.2 82.3 1.1 [0.8–1.6] 0.576
50–70 years old 87.9 83.1 o0.001 1
470 years old 67.6 52.4 2.0 [1.5–2.6] o0.001
Marital status
Alone 78.5 69.9 0.003 0.9 [0.7–1.2] 0.521
Not alone 84.2 78.1 1
Number of children
0 or 1 78.3 69.6 0.004 1.0 [0.8–1.3] 0.754
2 or more 84.6 78.2 1
Occupational status
Farmers, artisans, manual workers, unemployed 77.4 69.4 o0.001 1.3 [0.9–1.8] 0.106
Executives, middle professional group, clerical employees 88.2 83.0 1
Socio-economic status
Low 81.9 74.0 0.002 1.1 [0.8–1.7] 0.568
High 89.7 84.5 1
Mammographies during the 6 years before diagnosis
None 72.0 62.9 o0.001 1.5 [1.1–2.0] 0.004
One or more 90.0 85.3 1
Gynaecological consultation
None 73.7 60.5 o0.001 1.5 [1.1–2.2] 0.017
One or more 89.5 85.4 1
Cancer detected by screening mammography
No 80.7 72.6 o0.001 1.6 [1.05–2.3] 0.030
Yes 94.0 91.2 1
Stage TNM
T1 N0 M0 93.8 89.2 1
T2 and/or N+ M0 80.7 71.7 o0.001 2.6 [1.9–3.6] o0.001
T3 or T4 and/or M1 44.6 33.9 7.1 [4.9–10.3] o0.001
Abbreviation: CI¼confidence interval.
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from differences in the screening programmes in the counties may
have influenced the stage at diagnosis. In addition, survival in the
Bas-Rhin county was affected because it was included from 1995,
when detection practices were not as good, and not 1997 as in
other counties.
The surrogate way of life according to marital status (alone or
not) was no longer significant in multivariate survival analyses,
partly because of its correlation with age at diagnosis (older
women are more often alone), surveillance practices (women not
alone had better medical follow-up: more often went to a
gynaecologist, had a mammography and their diagnosis mammo-
graphy was more often performed in a screening framework) and
number of children (such women are not alone). Furthermore, age
and surveillance practices were independently associated with
length of survival.
In contrast to another study (Kroman et al, 1998), parity was
significant in multivariate analysis: as expected, it was associated
having a partner, and with occupational and socio-economic
status, but not in the same way; women in manual jobs and those
with a low socio-economic status were more likely to have two or
more children compared with those in the professions and with a
high socio-economic status. However, the association with earlier
stage at diagnosis was due to surveillance practices: women who
Patients
 A   232    228   227  219  181 
 B    706    643   588  535  410 
_______ ______ : A, mammography within the framework of screening  
_______ ______ : B, mammography carried out on clinical symptom or because of high-risk
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Figure 1 Overall survival distribution according to the circumstances of
diagnosis mammography (Kaplan–Meier estimate).
Table 4 Screening mammography as a prognostic factor of survival, by age and by stage at diagnosis: descriptive, 5-year overall survival rate and overall
survival in univariate analysis
Circumstances of diagnosis mammography n (%)
5-year overall
survival (%)
Univariate analysis
P-value (log rank)
Age at diagnosis
o50 years old n¼253
Screening mammography 46 (18.2) 95.7 0.005
On clinical symptom or high-risk 207 (81.8) 84.1
From 50 to 70 years old n¼514
Screening mammography 172 (33.5) 93.6 0.011
On clinical symptom or high-risk 342 (66.5) 87.1
470 years old n¼234
Screening mammography 31 (13.2) 93.7 o0.001
On clinical symptom or high-risk 203 (86.8) 66.5
Cancer stage at diagnosis
1 and 2: T1 N0 M0 n¼343
Screening mammography 126 (36.7) 94.4 0.417
On clinical symptom or high-risk 217 (63.3) 93.1
3: T2 and/or N+ M0 n¼391
Screening mammography 52 (13.3) 98.1 0.002
On clinical symptom or high-risk 339 (86.7) 77.9
T1 N+ M0 n¼133
Screening mammography 26 (19.5) 100 0.009
On clinical symptom or high-risk 107 (80.5) 78.5
T2 N0 M0 n¼128
Screening mammography 17 (13.3) 94.11 0.046
On clinical symptom or high-risk 111 (86.7) 82.9
T2 N+ M0 n¼126
Screening mammography 8 (6.3) 100 0.833
On clinical symptom or high-risk 118 (93.7) 72.9
4: T3 or T4 and/or M1 n¼88
Screening mammography 5 (5.7) 80.0 0.159
On clinical symptom or high-risk 83 (94.3) 50.6
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tion or mammography than other women had. Finally, the number
of children was also associated with age at diagnosis: women below
70 at diagnosis were more likely to have two or more children
compared with those diagnosed at an older age.
In our study, the socio-economic variable ‘occupational’ was an
independent prognostic factor of stage at diagnosis and of overall
survival: the higher the occupational status, the better the stage
and the longer the survival, as found in other studies (Thomson
et al, 2001; Cross et al, 2002; Taylor and Cheng, 2003; Lagerlund
et al, 2005; Downing et al, 2007). In France, it is difficult to obtain
individual socio-economic data and to make comparisons with
other varied studies. Our occupational subgroups probably
encompassed varied social conditions, and our variable socio-
economic status has no impact after adjustment. In Denmark, a
population-based study of 28765 cases (Dalton et al, 2006) showed
that the risk of a high-risk breast cancer increased with reduced
income, and with lower educational level. In the United States,
SEER data showed that African-Americans had higher mortality
even after adjustment for socio-economic factors (Grann et al,
2006). Even though stage at diagnosis explain part of the socio-
economic differences in survival (Kaffashian et al, 2003; Lehto
et al, 2006), future studies in France should use both patient data
and area-based methods to quantify the effect of socio-economic
variables on stage and survival more precisely; the role of
financial difficulties, accessibility of health care and lifestyle need
exploring in greater depth, as well as definitions of socio-economic
profiles.
Surveillance and prevention practices were found to be major
prognostic factors for survival. Having no mammography in the 6
years preceding diagnosis decreases 5-year survival by 18% and 7-
year survival by more than 22% (Po0.001). Comparing women
with one or more mammography to those who had none, we
observed a reduced death risk hazard of 1.8 (95% CI¼[1.4–2.3];
Po0.001) 9 years after diagnosis. Similarly, women who regularly
consulted a gynaecologist had a survival benefit of 25%, 7 years
after diagnosis, whereas those with none in the 3 years before
diagnosis had an increased death risk hazard of 1.8 (95%
CI¼[1.3–2.6]; Po0.001). With respect to public health policy,
these results suggest ways to improve survival.
We also found in multivariate analysis that asymptomatic
mammographic detection, rather than mammography performed
on clinical symptoms or because of a high risk of breast cancer,
was a prognostic factor of survival. Patients who had their
diagnosis mammography performed within the screening frame-
work had better survival of 13.3% at 5 years, and 18.6% at 7 years
(Po0.001), whereas the others who had mammography after the
onset of clinical symptoms, or because they belonged to a high risk
group, had an increased death risk hazard of 2.2 (95% CI¼[1.5–
3.2]; Po0.001). Other studies have also found that screening
detected smaller tumours with a more favourable prognosis
compared with those clinically detected (Fracheboud et al, 2004;
Anttinen et al, 2006).
However, to our knowledge, mammography itself as a mode of
detection has rarely been demonstrated as an independent
prognostic factor in women who all had a diagnosis mammo-
graphy, and in a population-based study, that is to say without any
intervention or evaluation. In one study breast cancers detected
initially by mammography, and after adjusting for stage, showed
significantly higher survival than symptomatic cases (Gill et al,
2004); this persisted throughout the 9-year-period of follow-up, as
in our study. Another showed that screening-detected tumours
were associated with better 10-year disease-free survival than
women those found outside screening (Joensuu et al, 2004). There
could also be a reduction in advanced-stage tumours and an
increase of more favourable low-stage tumours after several years
of ongoing screening (McCann et al, 1998; Buiatti et al, 2003).
Whatever the stage at diagnosis, surveillance practices and the
circumstances of the diagnosis mammography remain significant
in multivariate analysis. Even though screening mammography
offers better survival by way of a lower stage, unsurprisingly it is
also an independent prognostic factor, whatever the stage. It is no
surprise that the stage at diagnosis is a very strong prognostic
factor for survival. Lastly, it is that in multivariate analysis, county
of residence is no longer significant, these pre-diagnosis disparities
disappearing with treatment.
Mass screening programmes are offered only to women aged
50–74 years. Breast cancer has increased in women under 50 in
recent years, and as shown by Brenner and Hakulinen (2004), the
protective effect of asymptomatic detection persists for decades.
We thus studied screening mammography as a prognostic factor
more closely. After adjusting for age, we showed that whatever
their age, women who had their diagnosis mammography within
the framework of screening had better survival more than 9 years
after diagnosis (P¼0.005, P¼0.011 and Po0.001, respectively).
We could not demonstrate any difference between screening-
detected cancers and clinically detected for stages 1, 2 and 4; but
for stage 3 (T2 and/or Nþ M0), we found much better survival
with tumours detected by screening mammography (P¼0.002).
This benefit is apparent for tumours larger than 2cm, which is
unlikely to be a result of lead time or length bias, but these
subclasses seem to be the more responsive to mass screening, and
it may be thought that when the tumour is small, whatever the
extent of node invasion, survival is better. However, due to sample
size limitations in the subgroups, these results should be
interpreted carefully and validated on a large sample.
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